{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:25:32Z","timestamp":1785180332912,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.2353\/ajpath.2009.090028","type":"journal-article","created":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T00:21:14Z","timestamp":1254442874000},"page":"2184-2196","source":"Crossref","is-referenced-by-count":61,"title":["\u03b23-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer"],"prefix":"10.1016","volume":"175","author":[{"given":"Swayamjot","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary A.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Jagadeeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion R.","family":"Zillhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Montag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Diane","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban K.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2009.090028_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.2353\/ajpath.2009.090028_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.2353\/ajpath.2009.090028_bib3","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.2353\/ajpath.2009.090028_bib4","first-page":"355","article-title":"The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited","volume":"5","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2009.090028_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.2353\/ajpath.2009.090028_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1398","article-title":"Tumor-specific expression of \u03b1V\u03b23 integrin promotes spontaneous metastasis of breast cancer to bone","volume":"8","author":"Sloan","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0002-9440(10)65730-6","article-title":"Adenoviral gene transfer of \u03b23 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma","volume":"153","author":"Hsu","year":"1998","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2009.090028_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin \u03b1V\u03b23 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.2353\/ajpath.2009.090028_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1158\/1078-0432.CCR-08-1028","article-title":"Proapoptotic function of integrin beta3 in human hepatocellular carcinoma cells","volume":"15","author":"Wu","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.1941","article-title":"Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors","volume":"15","author":"Reynolds","year":"2009","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090028_bib11","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1158\/0008-5472.CAN-03-3354","article-title":"Integrin \u03b23 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of \u03b23 overexpression in glioblastoma multiforme","volume":"64","author":"Kanamori","year":"2004","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/carcin\/23.2.237","article-title":"Overexpression of \u03b1v\u03b26 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade","volume":"23","author":"Ahmed","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.2353\/ajpath.2009.090028_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","article-title":"\u03b21-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro","volume":"73","author":"Strobel","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2009.090028_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/gyno.1995.1214","article-title":"Expression and function of \u03b21 and \u03b1v\u03b23 integrins in ovarian cancer","volume":"58","author":"Cannistra","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2009.090028_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/gyno.1996.0225","article-title":"Expression and localisation of \u03b1v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma","volume":"62","author":"Carreiras","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2009.090028_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10735-004-4273-0","article-title":"Expression of \u03b1V-associated integrin \u03b2 subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens","volume":"36","author":"Maubant","year":"2005","journal-title":"Journal of molecular histology J Med Histol"},{"key":"10.2353\/ajpath.2009.090028_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0046-8177(97)90033-2","article-title":"Expression of \u03b1v\u03b23 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas","volume":"28","author":"Liapis","year":"1997","journal-title":"Hum Pathol"},{"key":"10.2353\/ajpath.2009.090028_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<285::AID-IJC19>3.0.CO;2-L","article-title":"Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of \u03b1v\u03b23 integrins and vitronectin","volume":"80","author":"Carreiras","year":"1999","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2009.090028_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.1999.5572","article-title":"\u03b1v\u03b23 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation","volume":"75","author":"Cruet","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2009.090028_bib20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1200\/JCO.2006.06.6514","article-title":"Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma","volume":"25","author":"Nabors","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2009.090028_bib21","first-page":"891","article-title":"Enhanced c-erb B-2\/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A","volume":"53","author":"Yu","year":"1993","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib22","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/MCB.21.6.2118-2132.2001","article-title":"\u03b23A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3\/ets transcriptional silencing element in the u-PAR promoter","volume":"21","author":"Hapke","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.2353\/ajpath.2009.090028_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2009.090028_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"C-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib25","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1074\/jbc.274.23.16377","article-title":"Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor\/scatter factor (HGF\/SF)","volume":"274","author":"Ried","year":"1999","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.090028_bib26","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-cadherin promotes ovarian cancer metastasis via \u03b15-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib27","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","article-title":"Let-7 expression defines two differentiation stages of cancer","volume":"104","author":"Shell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.090028_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0102-27","article-title":"Enhanced pathological angiogenesis in mice lacking \u03b23 integrin or \u03b23 and \u03b25 integrins","volume":"8","author":"Reynolds","year":"2002","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090028_bib29","doi-asserted-by":"crossref","first-page":"37256","DOI":"10.1074\/jbc.M605344200","article-title":"Intracranial microenvironment reveals independent opposing functions of host \u03b1V\u03b23 expression on glioma growth and angiogenesis","volume":"281","author":"Kanamori","year":"2006","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.090028_bib30","first-page":"277","article-title":"Pathology of the peritoneum: a review of selected topics","volume":"8","author":"Daya","year":"1991","journal-title":"Semin Diagn Pathology"},{"key":"10.2353\/ajpath.2009.090028_bib31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ijc.22874","article-title":"Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells","volume":"121","author":"Kenny","year":"2007","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2009.090028_bib32","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1073\/pnas.96.5.2147","article-title":"p53 regulates a G2 checkpoint through cyclin B1","volume":"96","author":"Innocente","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.090028_bib33","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1038\/sj.onc.1207233","article-title":"Microtubule-targeted anticancer agents and apoptosis","volume":"22","author":"Bhalla","year":"2003","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2009.090028_bib34","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2009.090028_bib35","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1073\/pnas.89.5.1557","article-title":"Role of the \u03b1v\u03b23 integrin in human melanoma cell invasion","volume":"89","author":"Seftor","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.090028_bib36","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1158\/0008-5472.CAN-06-4499","article-title":"Tumor \u03b1v\u03b23 integrin is a therapeutic target for breast cancer bone metastases","volume":"67","author":"Zhao","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1025461507027","article-title":"Inhibition of \u03b1v\u03b23 integrin reduces angiogenesis, bone turnover, and tumor proliferation in experimental prostate cancer bone metastases","volume":"20","author":"Nemeth","year":"2003","journal-title":"Clin Exp Metastasis"},{"key":"10.2353\/ajpath.2009.090028_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/bbrc.1996.1313","article-title":"Integrin \u03b23 cDNA transfection into a highly metastatic \u03b1v\u03b23-negative human melanoma cell line inhibits invasion and experimental metastasis","volume":"226","author":"Danen","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.2353\/ajpath.2009.090028_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","article-title":"14-3-3 sigma is a p53-regulated inhibitor of G2\/M progression","volume":"1","author":"Hermeking","year":"1997","journal-title":"Mol Cell"},{"key":"10.2353\/ajpath.2009.090028_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.semcancer.2006.03.002","article-title":"14-3-3 proteins in cell cycle regulation","volume":"16","author":"Hermeking","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.2353\/ajpath.2009.090028_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/352345a0","article-title":"Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6","volume":"352","author":"Yonish-Rouach","year":"1991","journal-title":"Nature"},{"key":"10.2353\/ajpath.2009.090028_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/med.10054","article-title":"Clinical relevance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer","volume":"24","author":"Edo de Bock","year":"2004","journal-title":"Med Res Rev"},{"key":"10.2353\/ajpath.2009.090028_bib43","first-page":"2396","article-title":"Increased expression of matrix metalloproteinases (MMP)-2. MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer","volume":"7","author":"Schmalfeldt","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib44","doi-asserted-by":"crossref","first-page":"26340","DOI":"10.1074\/jbc.M100181200","article-title":"Integrin \u03b1v\u03b23\/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells","volume":"276","author":"Hapke","year":"2001","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2009.090028_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10637-007-9077-0","article-title":"Phase I and pharmacokinetic study of etaracizumab (Abegrin\u2122), a humanized monoclonal antibody against \u03b1v\u03b23 integrin receptor, in patients with advanced solid tumor","volume":"26","author":"Delbaldo","year":"2008","journal-title":"Invest New Drugs"},{"key":"10.2353\/ajpath.2009.090028_bib46","first-page":"4263","article-title":"Cilengitide targeting of \u03b1v\u03b23 integrin synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts","volume":"62","author":"Burke","year":"2002","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.090028_bib47","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1158\/1078-0432.CCR-04-1223","article-title":"Inhibition of \u03b1v\u03b23 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy","volume":"11","author":"Abdollahi","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010607262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010607262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T02:24:10Z","timestamp":1549592650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010607262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0002944010607262"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2009.090028","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}